Literature DB >> 8314443

Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus.

E J Stevens1, M J Lockett, A L Carrington, D R Tomlinson.   

Abstract

In rats with 6 weeks streptozotocin-diabetes there was a 53% reduction in sciatic nerve laser Doppler flux compared to controls (p < 0.01). Treatment of a parallel group of diabetic rats with evening primrose oil, by dietary admixture throughout the protocol, prevented this ischaemia (Doppler flux was 91% of evening primrose-oil-treated controls and was not significantly different). There were no differences in systemic arterial pressure. In another experiment evening primrose oil markedly antagonised the development of exaggerated resistance to anoxic conduction failure in sciatic nerves from diabetic rats. The resistance to anoxia of nerves from non-diabetic rats was also reduced by evening primrose oil. These observations suggest that the sciatic nerves of diabetic rats with short-term streptozotocin-diabetes are markedly ischaemic and that this ischaemia is involved in the development of increased resistance to anoxic/ischaemic conduction failure in diabetic nerve. The findings also promote evening primrose oil as a potential treatment to prevent nerve ischaemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8314443     DOI: 10.1007/bf00402274

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Sural nerve oxygen tension in diabetes.

Authors:  P G Newrick; A J Wilson; J Jakubowski; A J Boulton; J D Ward
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

2.  Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats.

Authors:  D R Tomlinson; J P Robinson; A M Compton; P Keen
Journal:  Diabetologia       Date:  1989-09       Impact factor: 10.122

3.  Prostaglandin E1 modifies nerve conduction and interferes with local anaesthetic action.

Authors:  D F Horrobin; L G Durand; M S Manku
Journal:  Prostaglandins       Date:  1977-07

Review 4.  Diabetic neuropathy.

Authors:  D A Greene; A F Sima; M A Pfeifer; J W Albers
Journal:  Annu Rev Med       Date:  1990       Impact factor: 13.739

5.  Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy.

Authors:  P A Low; J D Schmelzer; K K Ward; J K Yao
Journal:  Am J Physiol       Date:  1986-01

6.  Essential fatty acids prevent slowed nerve conduction in streptozotocin diabetic rats.

Authors:  P O Julu
Journal:  J Diabet Complications       Date:  1988 Oct-Dec

Review 7.  Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?

Authors:  D A Greene; S A Lattimer; A A Sima
Journal:  Diabetes       Date:  1988-06       Impact factor: 9.461

8.  The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na+/K+ pump in streptozotocin-diabetic rats.

Authors:  M J Lockett; D R Tomlinson
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

Review 9.  Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy? The 1988 Robert Wartenberg lecture.

Authors:  P J Dyck
Journal:  Neurology       Date:  1989-01       Impact factor: 9.910

10.  Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235.

Authors:  H Yasuda; M Sonobe; M Yamashita; M Terada; I Hatanaka; Z Huitian; Y Shigeta
Journal:  Diabetes       Date:  1989-07       Impact factor: 9.461

View more
  10 in total

1.  Essential fatty acid treatment of rats with experimental diabetes: comment.

Authors:  L O Simpson
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

Review 2.  Vascular factors in diabetic neuropathy.

Authors:  S Tesfaye; R Malik; J D Ward
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

3.  Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids.

Authors:  C Karasu; M Dewhurst; E J Stevens; D R Tomlinson
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

4.  Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models.

Authors:  E J Stevens; A L Carrington; D R Tomlinson
Journal:  Diabetologia       Date:  1994-01       Impact factor: 10.122

5.  Restoring lower limb blood flow improves conduction velocity in diabetic patients.

Authors:  M J Young; A Veves; J V Smith; M G Walker; A J Boulton
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

6.  Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes.

Authors:  E J Stevens; D R Tomlinson
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

7.  Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism.

Authors:  N E Cameron; M A Cotter; K C Dines; E K Maxfield; F Carey; D J Mirrlees
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

8.  Effects of evening primrose oil treatment on sciatic nerve blood flow and endoneurial oxygen tension in streptozotocin-diabetic rats.

Authors:  N E Cameron; M A Cotter
Journal:  Acta Diabetol       Date:  1994-12       Impact factor: 4.280

9.  Deficient nitric oxide responsible for reduced nerve blood flow in diabetic rats: effects of L-NAME, L-arginine, sodium nitroprusside and evening primrose oil.

Authors:  N Omawari; M Dewhurst; P Vo; S Mahmood; E Stevens; D R Tomlinson
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

10.  Protective effects of Borago officinalis extract on amyloid β-peptide(25-35)-induced memory impairment in male rats: a behavioral study.

Authors:  Fatemeh Ghahremanitamadon; Siamak Shahidi; Somayeh Zargooshnia; Ali Nikkhah; Akram Ranjbar; Sara Soleimani Asl
Journal:  Biomed Res Int       Date:  2014-06-11       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.